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Abstract
Background: Cardiorespiratory fitness (VO2max) is an excellent predictor of chronic disease morbidity and mortality
risk. Guidelines recommend individuals undertake exercise training to improve VO2max for chronic disease reduction.
However, there are large inter-individual differences between exercise training responses. This systematic review is
aimed at identifying genetic variants that are associated with VO2max trainability.
Methods: Peer-reviewed research papers published up until October 2016 from four databases were examined.
Articles were included if they examined genetic variants, incorporated a supervised aerobic exercise intervention;
and measured VO2max/VO2peak pre and post-intervention.
Results: Thirty-five articles describing 15 cohorts met the criteria for inclusion. The majority of studies used a cross-
sectional retrospective design. Thirty-two studies researched candidate genes, two used Genome-Wide Association
Studies (GWAS), and one examined mRNA gene expression data, in addition to a GWAS. Across these studies, 97
genes to predict VO2max trainability were identified. Studies found phenotype to be dependent on several of these
genotypes/variants, with higher responders to exercise training having more positive response alleles than lower
responders (greater gene predictor score). Only 13 genetic variants were reproduced by more than two authors.
Several other limitations were noted throughout these studies, including the robustness of significance for
identified variants, small sample sizes, limited cohorts focused primarily on Caucasian populations, and minimal
baseline data. These factors, along with differences in exercise training programs, diet and other environmental
gene expression mediators, likely influence the ideal traits for VO2max trainability.
Conclusion: Ninety-seven genes have been identified as possible predictors of VO2max trainability. To verify the
strength of these findings and to identify if there are more genetic variants and/or mediators, further tightly-
controlled studies that measure a range of biomarkers across ethnicities are required.
Keywords: Cardiorespiratory fitness, VO2max, Predictor genes, Training
Background
The worldwide prevalence of chronic diseases, such as
cardiovascular disease, cancers, stroke and diabetes is
rising [1]. Low cardiorespiratory fitness is strongly asso-
ciated with chronic diseases and premature mortality
[2–7]. To alleviate the health and economic burden as-
sociated with low cardiorespiratory fitness, health
guidelines across the world recommend individuals
undertake regular exercise [1].
Exercise training can increase cardiorespiratory fitness
and decrease chronic disease via a number of mecha-
nisms [7]. Adaptations include improvements to cardiac
size, stroke volume (increase in volume of blood
pumped from the left ventricle), cardiac output (volume
of blood pumped from the heart per minute), pulmonary
blood flow and respiratory function, supply of oxygen-
rich blood to working muscles (increased number of
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capillaries and blood volume), muscle mitochondrial
function and content, oxidative enzyme capacity, vascu-
lar wall health and function, and biomechanical effi-
ciency [2, 7]. It has been suggested that improvements
in cardiorespiratory fitness in response to exercise train-
ing varies greatly between individuals, with some people
responding well or very well (‘responders’ or ‘high-re-
sponders’) to exercise training, whereas others only have
mild increases in their cardiorespiratory fitness following
similar exercise training (‘low-responders’) [4, 5, 8–11].
Importantly, these responses need to be compared to
within-subject random variation to ascertain true inter-
individual differences [12]. The ability to change cardio-
respiratory fitness is a multifactorial trait influenced by
environmental factors (such as exercise training) and
genetic factors [4, 5, 11]. Considering cardiorespiratory
fitness is one of the best integrative predictors of mor-
bidity and mortality risk, it may be important to under-
stand how genetics predict the variability in response to
exercise training. This knowledge could lead to targeted
personalised exercise therapy to decrease the burden of
chronic disease.
The gold standard measure for cardiorespiratory fit-
ness is maximal oxygen uptake (VO2max), which is quan-
tified as the maximal amount of oxygen the body can
use in 1 min, during dynamic work with large muscle
mass [13]. Research into human variation of VO2max was
first undertaken over forty years ago, with several au-
thors identifying a strong genetic influence on VO2max
in twins [14, 15]. Subsequent studies have identified sig-
nificant familial aggregation for VO2max trainability. For
example, authors have found greater variance between
pairs of monozygotic (MZ; identical) twins than within
pairs of twins for VO2max training response after stan-
dardized aerobic training interventions [16, 17]. The
strongest evidence to date on this topic was found in the
HEalth, Risk factors, exercise training And GEnetics
(HERITAGE) family study [18]. Four hundred seventy-
three Caucasian adults from 99 nuclear families com-
pleted 20 weeks of Moderate Intensity Continuous
Training (MICT). The average increase in VO2max was
400 mL O2/min, with a range from − 114 to + 1097 mL/
min. This difference was two and half times greater be-
tween families than within families, with a 47% heritabil-
ity estimate for VO2max training response [18]. A major
limitation from these findings, however, is there was no
comparator control group.
Since this familial longitudinal research, the Human
Genome Project completed sequencing of the human
genome resulting in significant advancements in genetic
analysis capabilities. This led to a better understanding
of genetic variations of large populations. Analyzing gen-
etic variants on a population level using techniques such
as candidate gene analysis, GWAS, whole genome and
exome sequencing and RNA expression analysis (RNA-
seq, or microarrays) has resulted in the possibility of
developing ‘personalized genomics’. This aims for bio-
logical profiling to provide more effective health man-
agement and treatment [5]. However, research in the
field of exercise genomics it still in its infancy and much
work is needed before genomic tools could be utilized to
personalize exercise training programs [19].
The aim of this study was to systematically review the
literature and identify genetic variants that have been
associated with VO2max trainability following an aerobic
exercise training intervention. Given the infancy of this
research field, results should only be used to provide the
basis for future research. This research should aim to
confirm previous findings and investigate mediators that
can influence gene expression. Importantly, future gen-
etic studies in this area should attempt to investigate the
physiological functions that contribute to improving
VO2max training response and overall health outcomes.
Findings from ongoing research may assist clinical pro-
fessionals to provide personalized evidenced-based
medicine centered on phenotype, contributing to the
fight against chronic disease.
Methods
A comprehensive search of four databases (PubMed,
Embase, Cinahl, Cochrane) was completed from their
inception until October 2016. Studies focusing on genes
and their VO2max/VO2peak response to supervised aer-
obic training were sought with the following search
terms: genetic profiling, polymorphism, single nucleo-
tide polymorphisms, SNPs, genetic variants, predictor
genes, trainability, endurance training, cardiovascular
fitness, cardiorespiratory fitness, VO2max, VO2peak, aerobic
power, aerobic fitness, aerobic capacity. A full list of search
terms can be found at the end of this review.
Two authors (CW and JC) agreed on the criteria for
inclusion. Articles were incorporated if they were: ori-
ginal, peer-reviewed research; included an aerobic inter-
vention, with minimum 75% supervision; included genetic
variant testing; included a maximal VO2max/peak using
direct gas analysis from an incremental test (pre and post
intervention); conducted on humans; and written in
English.
Using an extraction grid, one author (CW) conducted
the initial screening analysis. After removing duplicates
and scanning the titles and abstract of articles, those
meeting the inclusion criteria were reviewed. Data re-
corded from the review consisted of the author’s name
and place of study, study design, study sample, tissue
source, genotyping method used, gene and variant exam-
ined, genotype, gene expression (if examined), interven-
tion used, possible mediators (such as medications and
health concerns), and the influence of the genetic variant
The Author(s) BMC Genomics 2017, 18(Suppl 8):831 Page 82 of 131
investigated on VO2max change. Further articles were
retrieved from snowballing included articles from
their reference lists. Articles included in the review
are in Table 1.
A summary of key findings from the included articles
is provided in Tables 2 and 3. Limitations were assessed
by two authors (CW and JC) based on the intervention,
genotyping method used, study design and sample used.
Table 4 was developed to highlight which predictor
genes for VO2max trainability merited further explo-
ration. A third author (MW) examined Tables 1, 2, 3
and 4 to ensure all genetic variants, genomic coordi-
nates and genotypes, were described with a consistent
annotation.
Results
Of the 1635 articles identified, 35 met the inclusion cri-
teria (see Fig. 1). A summary of these articles is provided
in Tables 1, 2 and 3. From the 35 articles, 97 genetic var-
iants were identified as being significantly associated
with VO2max trainability (Table 4).
Study characteristics
Across the studies DNA samples from 4212 individuals
were used. Tissue sources were predominantly blood
leucocytes, lymphoblastoid cell lines and buccal cells.
Genotype was primarily identified through PCR-RFLP
(polymerase chain reaction restriction fragment length
polymorphism based analysis) for candidate genes and
Illumina Human CV370-Quad Bead Chips for GWAS
analysis (which can capture over 370,000 SNPs per
participant).
Overall, 68% of participants in the reviewed studies
were men, and ages ranged from 17 to 75 years. The
average BMI of participants was 25.3 kg/m2 (SD 2.36).
Where detailed, DNA samples were taken from a variety
of ethnicities, including Caucasian (74.5%), Asian
(13.5%), African-American (7.5%), Hispanic (4.3%) and
Native American (0.2%).
The 35 included articles described 15 cohorts, with
three cohorts providing subject data for 19 articles (see
Table 1 for details). Nine articles [20–28] used data
from the HERITAGE study and five [29–33] reviewed
Caucasian participant data from the Cardiac Rehabilita-
tion and Genetics of Exercise Performance and Train-
ing Effect (CARAGENE) study. Five studies examined
clinical data from 102 young male and apparently healthy
police recruits in China [34–38]. The remaining samples
came from independent clinical studies focusing on appar-
ently healthy but sedentary adults from a variety of ethnic-
ities including Caucasians, Asians, African-Americans,
Native American and Hispanics [13, 39–53].
Most reviewed studies (n = 32) used a single-group
longitudinal design. However, one study compared three
groups using a longitudinal design [28]. One study used
retrospective data from two Randomized Controlled Tri-
als (RCT) [20]; and one was a double-blind study [39].
Twenty-eight studies examined a MICT intervention.
Two studies examined protocols using High Intensity
Interval Training (HIIT) [28, 40]. The 5 remaining stud-
ies trained participants by running at Ventilatory
Threshold (VT) [34–38]. Training intensity was mea-
sured using a percentage of VO2max, Heart Rate Reserve
(HRR), VT, Maximal Power (Pmax) or Maximum Heart
Rate (HRmax). Intensities varied between 50 and 85%
VO2max, 95% -105% VT, 50–85% Pmax, 80–85% HRR
and 50–80% HRmax. Training volume varied between 20
to 90 min per session (2-4×/week). The period of inter-
ventions ranged from 4 weeks to 9 months. Training
modalities consisted primarily of cycle ergometers and
treadmills.
Only six studies incorporated a standardized diet
prior to and during the intervention period [23, 41–45].
Three articles included strength training [20, 39, 47]
and two studies included military training [39, 47] as
the intervention.
Genotyping findings
1. Candidate gene studies
The candidate gene association approach requires a
prior hypothesis that the genetic polymorphisms of
interest are causal variants or in strong linkage disequi-
librium (LD) with a causal variant, and would be associ-
ated with a particular exercise-related phenotype at a
significantly different rate than predicted by chance
alone (may be higher or lower). This approach is effect-
ive in detecting genetic variants that are either directly
causative, or belong to a shared haplotype that is causa-
tive [54]. Thirty-two candidate gene studies were based
on the gene’s molecular function and possible associ-
ation with VO2max trainability (Table 2).
Genes associated with muscular subsystems
VO2peak can be influenced by muscle efficiency and it
has been hypothesized that genes encoding muscular
subsystems may contribute to the genetic variability in
VO2peak training response [33]. Twelve genes and 21
genetic variants related to muscular phenotypes were in-
vestigated in 935 (76 female) cardiac patients from the
CARAGENE study [33]. Three out of the 21 genetic var-
iants were significantly associated (p < 0.05) with an in-
crease in VO2peak following 3 months of MICT (2–3 ×
90-min sessions per week at 80% HRmax; p < 0.05). These
variants included GR:c.68 > A (G/A genotype, number of
people with genotype; n = 55) in the glucocorticoid re-
ceptor gene (GR; rs6190), CNTF:c.115-6G > A (AA
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Table 4 Predictor genes that may influence VO2max training response




(x = candidate gene study)
1 1 AMPD1 rs17602729 Caucasian TT and CT (−) Thomaes, 2011 (x);
Rico-Sanz, 2003 (x)
2 1 CAMTA1 rs884736 Caucasian
African-American
AA (−) Bouchard, 2011;
Ghosh, 2013
3 1 ID3 rs11574 Caucasian TBC Timmons, 2010
4 1 RGS18 rs10921078 Caucasian
African-American
GG (−) Bouchard, 2011
5 1 RYR2 rs7531957 Caucasian TBC Bouchard, 2011;
Ghosh, 2013
6 1 SLC45A1 TBC Caucasian TBC Ghosh, 2013
7 2 ACVR1C TBC Caucasian TBC Ghosh, 2013
8 2 KCNF1 rs2003298 Caucasian TBC Bouchard, 2011
9 2 FLJ44450 rs4952535 Caucasian G (+) Bouchard, 2011
10 2 TTN rs10497520 Caucasian TBC Timmons, 2010
11 2 NRP2 rs3770991 Caucasian TBC Timmons, 2010
12 3 KCNH8 rs4973706 Caucasian A (+) Bouchard, 2011
13 3 ZIC4 rs11715829 Caucasian AA (−) Bouchard, 2011
14 3 NLGN1 rs2030398 Caucasian A (+) Bouchard, 2011
15 3 ADCY5 TBC Caucasian TBC Ghosh, 2013
16 4 CSN1S2B rs2272040 Caucasian TBC Bouchard, 2011
17 4 LOC100289626 rs2053896 Caucasian A (+) Bouchard, 2011
18 4 ACSL1 rs6552828 Caucasian AA (−) Bouchard, 2011;
Ghosh, 2013
19 4 SLED1 rs6552828 Caucasian TBC Ghosh, 2013
20 4 PRR27; C4orf40 rs3775758 Caucasian TBC Ghosh, 2013
21 4 TEC rs13117386 Caucasian TBC Ghosh, 2013
22 5 NR3C1 rs6190 Caucasian GG (−) Thomaes, 2011
23 5 NLN TBC Caucasian TBC Ghosh, 2013
24 5 FABP6 rs7734683 Caucasian TBC Ghosh, 2013
25 5 TTC1 rs2176830 Caucasian TBC Bouchard, 2011
26 6 PPARD Exon 4 + 15
Exon 7 + 65
African-American CC (−) Hautala, 2007 (x)
27 6 HCG22 rs2517512 Caucasian TBC Ghosh, 2013
28 6 HCG22 rs2523849 Caucasian TBC Bouchard, 2011
29 6 HCG22 rs2523848 Caucasian TBC Bouchard, 2011
30 6 HCG22 rs2428514 Caucasian TBC Bouchard, 2011
31 6 HCG22 rs2517518 Caucasian TBC Bouchard, 2011
32 6 HCG22 rs2523840 Caucasian TBC Bouchard, 2011
33 6 HCG22 rs2517506 Caucasian TBC Bouchard, 2011
34 6 PRDM1 rs10499043 Caucasian A (+) Bouchard, 2011
35 6 ENPP3 rs10452621 Caucasian A (+) Bouchard, 2011
36 6 SLC22A3 rs2457571 Caucasian Downregulated in
high responders
Timmons, 2010
37 6 TMEM181 TBC Caucasian TBC Ghosh, 2013
38 6 PARK2 TBC Caucasian TBC Ghosh, 2013
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Table 4 Predictor genes that may influence VO2max training response (Continued)




(x = candidate gene study)
39 6 SNX14 TBC Caucasian TBC Ghosh, 2013
40 6 BTBD9 TBC Caucasian TBC Ghosh, 2013
41 6 KCNQ5 TBC Caucasian TBC Ghosh, 2013
42 7 HDAC9 rs3814991 Caucasian TBC Bouchard, 2011
43 7 WBSCR17 rs12538806 Caucasian TBC Bouchard, 2011
44 7 WBSCR17 rs13235325 Caucasian TBC Bouchard, 2011
45 7 CPVL rs4257918 Caucasian TBC Timmons, 2010
46 7 ITGB8 rs10265149 Caucasian TBC Ghosh, 2013
47 7 LHFPL3 TBC Caucasian TBC Ghosh, 2013
48 8 DEPDC6 rs7386139 Caucasian TBC Timmons, 2010
49 8 PINX1 TBC Caucasian TBC Ghosh, 2013
50 9 GRIN3A rs1535628 Caucasian TBC Bouchard, 2011
51 9 GRIN3A rs959066 Caucasian TBC Bouchard, 2011
52 9 C9orf27 rs12115454 Caucasian G (+) Bouchard, 2011
53 9 TTLL11 rs7022103 Caucasian TBC Ghosh, 2013
54 9 KCNT1 TBC Caucasian TBC Ghosh, 2013
55 10 FAM238B; LOC731789 rs11015207 Caucasian TBC Ghosh, 2013
56 10 PRKG1 TBC Caucasian TBC Ghosh, 2013
57 10 SVIL rs6481619 Caucasian TBC Timmons, 2010
58 10 BTAF1 rs2792022 Caucasian TBC Timmons, 2010
59 10 CASC2 rs1413184 Caucasian TBC Ghosh, 2013
60 11 H19 rs22551375 Caucasian Upregulated in
high responders
Timmons, 2010
61 11 LOC100130460 rs2198009 Caucasian A (+) Bouchard, 2011
62 11 DBX1 rs10500872 Caucasian A (+) Bouchard, 2011
63 11 CD44 rs353625 Caucasian TBC Bouchard, 2011;
Ghosh, 2013
64 11 CXCR5 (36 kb) rs4938561 Caucasian TBC Bouchard, 2011
65 11 CXCR5 (24 kb)/BLR1 rs7933007 Caucasian TBC Bouchard, 2011
66 11 CD6 rs175098 Caucasian TBC Ghosh, 2013
67 11 SHANK2 rs10751308 Caucasian TBC Ghosh, 2013
68 11 GRIK4 TBC Caucasian TBC Ghosh, 2013
69 11 CNTF rs1800169 Caucasian AA (+) Thomaes, 2011 (x)
70 11 CAT -262C > T Caucasian TT (−) Onkelinx, 2011 (x)
71 11 GSTP1 c.313A > G (rs1695) Caucasian GG & AG (+) Zarebska, 2014 (x)
72 12 FAM19A2 rs2168452 Caucasian TBC Ghosh, 2013
73 12 C12orf36 rs12580476 Caucasian TBC Bouchard, 2011
Ghosh, 2013
74 13 NALCN TBC Caucasian TBC Ghosh, 2013
75 13 MIPEP rs7324557 Caucasian TBC Timmons, 2010
76 13 EEF1DP3 rs2773968 Caucasian TBC Ghosh, 2013
77 13 CLYBL NA Caucasian TBC Ghosh, 2013
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genotype, n = 21) in the ciliary neurotrophic factor gene
(CNTF; rs1800169) and the AMPD1:c.133C wild type
(CC genotype, n = 652) of the adenosine monophosphate
deaminase gene (AMPD1; rs17602729). Furthermore, a
larger change in relative VO2peak was reported in pa-
tients with a greater number of these variants described
(Area Under the Curve (AUC): 0.63; 95% Confidence
Interval (CI): 0.56–0.7; p < 0.01). More specifically, those
with a gene predictor score (GPS) of one or less positive
response alleles had an average increase in VO2peak of
16.7%. Those with four or more positive response alleles
had an average increase of 25%, with each positive re-
sponse allele contributing approximately 1% (13.5 mL/
min) to the increase in VO2peak.
Caucasians aged between 17 and 65 years from the
HERITAGE study who were homozygous (TT genotype)
for the AMPD1:c.133C > T (p.(Gln45*)) (rs17602729)
variant (n = 6), had a lower VO2max training response
(<121 mL/min; p = 0.006), compared to the CT and CC
genotypes (n = 497) following 20 weeks of MICT (3 ×
50 min per week at 55–75% HRmax) [46].
The serine/threonine protein kinase 1 (AKT1) gene
has been linked to growth and skeletal muscle differenti-
ation [44]. In a study of 109 Caucasians (50–75 years
old), men (n = 22) with the AKT1:c.-350G > T
(rs1130214) variant (TT/GT genotype) significantly in-
creased their VO2max compared to men (n = 29) with the
GG genotype (fold increase of 1.2 ± 0.02 vs 1.1 ± 0.02, p
= 0.037) following 24 weeks of MICT (3 × 20–40 min
per week at 50–75% HRR) [44].
The glutathione S-transferase P1 (GSTP1) c.313A >G
variant has been associated with an impaired ability to re-
move excess reactive oxygen species. This is hypothesised
to increase the exercise training response by better activa-
tion of cell signalling pathways resulting in positive muscle
adaptations [45]. While investigating 62 Polish females’
(19–24 years-old) response to 12 weeks of MICT (3 ×
60 min per week at 50–75% HRmax), participants (n = 30)
Table 4 Predictor genes that may influence VO2max training response (Continued)




(x = candidate gene study)
79 14 HIF1A T + 140C Caucasian (60+ years) C/T (−) Prior, 2003 (x)
80 14 AKT1 G205 T (RS1130214) Caucasian men GT & TT (+) McKenzie, 2011 (x)
81 14 TTC6 rs12896790 Caucasian C (+) Bouchard, 2011
82 14 DAAM1 rs1956197 Caucasian AA (−) Bouchard, 2011
83 15 NDN rs824205 Caucasian GG (−) Bouchard, 2011
84 15 DIS3L Rs1546570 Caucasian TBC Timmons, 2010




86 17 RPTOR NA Caucasian TBC Ghosh, 2013
87 17 VPS53 NA Caucasian TBC Ghosh, 2013
88 19 ADGRE3P; EMR4 rs7256163 Caucasian TBC Bouchard, 2011







90 19 CKM Ncol Caucasian Homozygous 1170
bp (−); CKM locus (+/−)
Rivera, 1999(x);
Rivera 1997 (x)
91 20 BIRC7 and YTHDF1 rs6090314 Caucasian A (+) Bouchard, 2011
Ghosh, 2013
92 20 YTHDF1 rs6122403 Caucasian TBC Ghosh, 2013
93 20 MACROD2 NA Caucasian TBC Ghosh, 2013
94 21 HLCS NA Caucasian TBC Ghosh, 2013
95 22 MN1 rs738353 Caucasian A (+) Bouchard, 2011
96 Mitochondria ALAS2 </=166 bp Chinese </=166 bp (+) Xu, 2015 (x)
97 Mitochondria mtDNA TBC Quebec, Tempe mtDNA subunit 5 N5 (−) Dionne, 1991 (x)
Where possible, gene variants were annotated using the references sequence (GRCh37/hg19)
Bolded = genes that have been replicated between or within studies
**(+) = high training response, (−) = low training response, (0) = neutral training response, TBC to be confirmed whether variant contributes to a high or low
training response
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with the GSTP1:c.313A >G (GG + GA genotype) demon-
strated a 2 mL/kg/min greater improvement in VO2max
compared to AA genotypes (n = 5) following training (ab-
solute p = 0.029, relative p = 0.026, effect size = 0.06) [45].
Genes associated with electrolyte balance
The electrogenic transmembrane ATPase (NA+/K +
−ATPase) gene may contribute to VO2max trainability by
affecting the electrolyte balance and membrane excit-
ability in working muscles [24]. Examining Caucasian
data from the HERITAGE study, it was found that those
homozygous for a recurrent 3.3-kb deletion in the exon
1 of the ATP1A2 gene (n = 5) had a 41% (45 mL/min)
lower training response compared to heterozygotes (n =
87) [24]. This exon encodes on part (alpha-2-subunit) of
the Na+/K + ATPase protein. This genotype also had a
48% (197 mL/min) lower VO2max training response than
homozygotes (n = 380) for a repeated 8.8-kb in the exon
1 of the ATP1A2 gene following 20 weeks of MICT
(p = 0.018) [24]. VO2max gains were 29% (130 mL/min)
and 39% (160 mL/min) greater in offspring homozygous
for a 10.5-kb deletion in exon 21–22 (n = 14) compared
to heterozygotes (n = 93) and homozygotes (n = 187) re-
spectively (p = 0.017) [24].
The angiotensin-converting enzyme (ACE) gene con-
tributes to blood pressure, fluid and salt balance [55].
Elite endurance athletes are more likely to have the In-
sertion (I) allele [56] which relates to lower ACE activity
and reduced blood pressure response during exercise,
whereas sprint/power athletes are more likely to have
the Deletion (D) allele and the DD genotype [57] and
subsequently higher ACE activity. Caucasians from the
CARAGENE study with the homozygous II genotype
(frequency of 0.23 and 0.18 for men and women respect-
ively) had a 2.1% greater VO2max training response (p =
0.047) compared to the DD genotype (frequency of 0.3
and 0.36 for men and women respectively) [31]. When
eliminating those on ACE inhibitors, the improvement
increased by 3% (p = 0.013) [31]. On the other hand,
VO2max trainability was 14–38% greater (p = 0.042) in
HERITAGE Caucasian offspring with the DD genotype
(n = 81) [25]. Three studies found no association with
ACE or angiotensinogen genetic variants and VO2max
training response in 53 Caucasians (average age 19 years)
following 12 weeks of military training [47]; 147 multi-
ethnic 19–24 year-old adults following 8 weeks of mili-
tary training [39]; and 83 Brazilian policemen (average
age 26 years) following 17 weeks of MICT (3 × 60 min
per week at 50–85% VO2peak) [48].
Genes associated with lipid metabolism
Genotypes of the perilipin (PLIN1) gene may influence
training response via intracellular lipolysis and energy
production [43]. In 101 Caucasians (50–75 years old),
there were no significant differences between carriers
and non-carriers of the PLIN1:c.504 T > A variant
(rs1052700) after 24 weeks of MICT (20–40 min, 3 ×
per week) [43].
Fig. 1 PRISMA flow chart of article selection process
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The peroxisome proliferator activated receptor delta
(PPARD) gene affects fatty acid oxidation and energy
production [22]. African-Americans (n = 19) from the
HERITAGE study with the PPARD exon 4 + 15 (CC
genotype) had a significantly lower VO2max training re-
sponse (> 50 mL/min lower; p = 0.028) and power out-
put (> 15 W lower; p = 0.005) compared to the C/T and
TT genotypes (n = 230) [22].
Apolipoprotein E (APOE) variants affect the level of
lipids in the blood, cell lipid uptake and endothelial vas-
cular dilation [23]. APOE has 3 common alleles: E2 (TT/
TT), E3 (TT/CC), E4 (CC/CC) at two SNPs (rs429358,
rs7412), which can create six possible genotypes (E2/E2,
E3/E3, E4/E4, E2/E3, E2/E4, E3/E4) [58]. The APOE E4
allele has been associated with Alzheimer’s disease [59],
higher levels of low density cholesterol (LDL-C) and a
greater risk of coronary heart disease compared to E3
(wild-type) and E2 carriers [23]. Chinese men (18–
40 years) with the APOE E2/E3 (n = 20) and E3/E4 (n =
31) genotypes had a significantly higher VO2max training
response (Odds Ratio (OR) = 0.68 (95% CI (0.04, 1.32); p
= 0.04 and OR = 0.60 (95% CI (0.09, 1.11); p = 0.02 re-
spectively) compared to other APOE genotypes following
6 months of progressive MICT (3 x per week at 60–85%
VO2max) [13]. Similarly, Chinese women (18–40 years)
with the APOE E2/E3 (n = 25) and E3/E4 (n = 29) geno-
types had significantly higher VO2max training responses
compared to other APOE genotypes (OR = 0.62 (95% CI
= 0.05, 1.18); p = 0.03 and OR = 0.62(95% CI = 0.09,1.15);
p = 0.02 respectively) [13]. Men and women (ethnicity
unknown) with the E3/E3 APOE genotype (n = 43) had
an 8% lower training response compared to the E2/E3
(n = 40) and E3/E4 genotypes (n = 37) (p < 0.01,
Bonferroni-corrected) following 6 months of MICT (4 ×
50 min per week at 60–85% VO2max) [42]. However,
there was no significant difference in the VO2max train-
ing response between APOE genotypes in men and
women from the HERITAGE study (n = 766) [23]. Simi-
larly, in 51 males (40–80 years old, ethnicity not con-
firmed) there was no difference in VO2max training
response between genotypes [41].
Genes associated with oxidative phosphorylation and
energy production
Mitochondrial DNA (mtDNA) encodes several enzyme
subunits involved in oxidative phosphorylation, and may
be a key factor in endurance and cardiorespiratory fit-
ness [56]. Research of mtDNA variants in 41 inactive
Japanese men (mean age 20.6) failed to find a significant
difference in trainability after 8 weeks of MICT (3–
4 × 60 min per week at 70% VO2max) [49]. On the con-
trary, 3 men (17–25 years) with the mtDNA variant in
subunit 5 of ND5 had a lower VO2max training response
compared to other mtDNA variants (~ gain 0.22 L/min
less, p < 0.05) following 12-weeks of MICT (3–5 ×
45 min per week at 85%HRRmax) [50].
The creatine kinase muscle (CKM) gene has been as-
sociated with reduced fatigue from increased adenosine
triphosphate (ADP) production [26, 27]. Using data from
the HERITAGE study, parents and offspring homozygote
for the 1170 bp allele (n = 12) had a lower VO2max train-
ing response (3 times and 1.5 times lower respectively; p
< 0.05) compared to other CKM genotypes (n = 148).
This explained 9 and 10% of the inter-individual vari-
ation in VO2max change respectively [26]. A nominal
genetic linkage was identified in siblings (n = 277) who
shared two alleles (1170 base pairs or 985 + 185 base
pairs) at the CKM locus identical by descent (IBD), with
these siblings having similar changes in VO2max com-
pared to siblings with fewer alleles IBD (p = 0.04) [27].
In an earlier study focusing on muscle specific inherited
variations, no association was found in 295 Caucasians
(18–30 years old) between CKM or adenylate kinase
(AK1) variants after a randomized control trial that in-
cluded 15 weeks of endurance training versus maximal
power contraction interval training [40]. Similarly, no as-
sociation was found with the CKM gene and VO2max
trainability in 937 Caucasian patients with coronary ar-
tery disease following 3 months of MICT (2–3 × 90 min
aerobic sessions per week at 80% HRmax) [29].
Nuclear respiratory factor 1 (NRF1) and nuclear factor
(erythroid-derived 2)-like 2 (NFE2L2) [36, 37], contrib-
ute to mitochondrial biogenesis and oxidative phosphor-
ylation [60]. In a study involving 102 physically active
Chinese male soldiers (average age 19 years), there was
no association between NRF1 and NFE2L2 genotypes or
haplotypes and VO2max trainability after 18 weeks of 3 ×
5000 m runs per week at 95–105% VT [36, 37].
Genes associated with oxygen delivery
Nitric oxide causes coronary and arterial vasodilation,
contributing to oxygen delivery regulation [32]. Data
from the CARAGENE study was used to investigate
genes associated with nitric oxide bioavailability [32].
These included nitric oxide synthase 3 (NOS3), cyto-
chrome b-245 alpha chain (CYBA, also known as p22-
PHOX), glutathione peroxidase (GPX1), catalase (CAT),
superoxide dismutase 3 (SOD3), vascular endothelial
growth factor A (VEGFA), peroxisome proliferator-
activated receptor alpha (PPARα) and peroxisome
proliferator-activated receptor gamma coactivator-
related 1 (PPARC1) [32]. Participants carrying the C al-
lele of the CAT:c.262 T > C variant (n = 342) had up to
3.1% greater improvements in VO2max training response
compared to participants with the TT genotype (n = 521)
following MICT (f = 3.6; p = 0.02). Participants with the
NOS3 1.4 haplotype combinations (n = 36) had a 6.4%
lower training response compared to the 3.3. haplotype
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combinations (n = 133) (p < 0.05). However, these associ-
ations were not significant after Bonferroni correction.
No other associations were found with other genes or
haplotypes related to nitric oxide availability and endo-
thelial function [32]. Similarly, in a cohort of 80 Portu-
guese (20–35 years old) police recruits, there was no
association between NOS3 genotypes (−786 TT/TC/CC,
894 GT/TT/GG) and VO2peak response following
18 weeks of 3 × 80-min per week of graded running
training [59]. Additionally, no association was found
with PPARGC1 and VO2max trainability in 102 Chinese
male polices recruits following MICT [36].
The beta-2-adrenergic receptor (ADBR2) gene helps to
support oxygen delivery to working muscles via the adren-
ergic receptors [30]. In participants from the CARAGENE
study, there was no association found between ADBR2 ge-
notypes or haplotypes, and VO2max trainability [30].
The hypoxia-inducible factor 1 alpha (HIF1A) gene is
a transcriptional regulator that controls angiogenesis
(blood vessel development) and metabolism by increas-
ing the expression of hypoxia-induced genes, such as
VEGF [52]. Caucasians 60 years and over with the
H1F1A:c.1744C > T (rs11549465; C/T genotype; n = 37)
had a significantly lower training response (0.3 mL/kg/
min; p = 0.03) compared to those with the CC genotype
(n = 64) following 24 weeks of MICT (3 × 20–40 min per
week at 50–70% VO2max) [52].
The 5′-aminolevulinate synthase 2 (ALAS2) gene is
highly expressed in erythroid cells and is imperative for
hemoglobin and myoglobin synthesis [53]. Seventy-two
Chinese participants (18–22 years old) allocated to one
of 13 ALAS2 genotypes with compound dinucleotide re-
peats lengths (157 bp −184 bp), were placed in a 4-week
‘HiHiLo’ training program (varying between low and
high altitude training at 75% VO2max) [53]. Baseline
hemoglobin levels and change in VO2max with training
was significantly higher in subjects (n = 25) with the di-
nucleotide repeats ≤ 166 bp (p < 0.05). No significant as-
sociations were found between VO2max trainability and
other genes related to oxygen transport and utilization
genotypes in 102 young Chinese soldiers following
18 weeks of 3 × 5000 m runs per week [35, 37, 38].
These genes include mitochondrial transcription factor
A (TFAM) [35] and hemoglobin-beta locus (HBB) [38].
2. Hypotheses free studies
Over the last decade, with the advent of technological
advances allowing researchers to genotype millions of
genetic variants (e.g. SNPs) in each individual, the inves-
tigation of the contribution of common variants to traits
is now feasible. Unbiased and hypothesis-free genome
wide association studies (GWAS) for exercise/health-re-
lated traits have emerged.
Three studies have used GWAS to identify genes as-
sociated with the VO2max response to exercise training
[20, 21 28]. These are outlined in Table 3.
The first investigated two clinical trials and data from
the HERITAGE study [28]. RNA expression profiling
and VO2max testing was performed on 24 healthy and in-
active Caucasian men (average age 24 years) before and
after a 6-week training intervention (4 × 45-min cycling
sessions per week at 70% VO2max). Muscle biopsies from
the vastus lateralis were collected and the RNA expres-
sion of genes was correlated with changes in VO2max by
analysing oligonucleotide arrays. Pearson correlations
were used to identify the relationships between the me-
dian logit normalised probe sets and the number of
times they were selected. In the 24 subjects, using a me-
dian correlation cut-off greater than 0.3, 29 genes were
selected greater than 22 out of 24 times. The sum of ex-
pression of these 29 genes were found to have a signifi-
cant linear relationship with VO2max change following
endurance training (r2 = 0.58, p < 0.00001). Across the
group, VO2max changes improved on average by 14% and
ranged from −2.8% to 27.5% (p = 0.0001). More than
20% of the group had a response less than 5%. A gene
set enrichment analysis found that the oxidative phos-
phorylation gene was upregulated (False Discovery Rate
(FDR) = 1.1%), which was associated with an increased
reliance on lipids during training (RER decreased on
average by 10% post training, p < 0.0001). To identify if
these predictor genes would be similar in a different
sample, a 12-week blind study on 17 young and active
Caucasian men was conducted. Training consisted of 1-
day of testing, 2 sessions of interval training (3 × 3-min
intervals at 40–85% Pmax) and 2 × 60–120-min cycle ses-
sions (55–60% Pmax) each week. The 29 predictor genes
were also significantly associated with VO2max trainabil-
ity in this group (p = 0.02). The haplotypes of these pre-
dictor genes were then genotyped using candidate genes
identified from the HERITAGE study. Six genetic vari-
ants were associated with VO2max trainability: SMTNL2,
DEPDC6, SLC22A3, METTL3, ID3 and BTNL9 (p < 0.01
each). A stepwise regression model using 25 variants
from the predictor set and 10 variants from the HERTI-
AGE study (Table 3) found that eleven SNPs (included
in Table 4) contributed to 23% of the differences seen in
residual VO2 max gains, which correlated to approxi-
mately 50% of the genetic variability in VO2max trainabil-
ity (seven variants from the RNA predictor set and four
from the HERITAGE project). Reciprocal RNA expres-
sion validation found that three of four HERITAGE can-
didate genes enhanced the original RNA transcript
predictor model. Overall, more than 90% of gene expres-
sion did not change. However, OCT3 was downregulated
in high responders and H19 was upregulated in low re-
sponders (FDR <5%). BTNL9, KLF4 and SMTNL2 also
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had small but inconsistent changes in expression (i.e.
dissimilar in high vs low responders) (FDR < 5%).
A GWAS examining 324,611 variants from the HERI-
TAGE study was completed to identify possible pre-
dictor genes associated with VO2peak [20]. Based on
single-variant analysis, 39 variants (Table 3) were as-
sociated with gains in VO2peak although none of these
achieved genome-wide or suggestive significance (p =
1.5 × 10−4) [19]. The strongest predictor for training
response was found in the Acyl-CoA synthetase long-
chain family member 1 (ACSL1) gene (4:g.185725416A >
G; rs6552828) which accounted for 7% of the training re-
sponse (p = 1.31 × 10−6). After a stepwise multiple regres-
sion analysis of the thirty-nine variants, 21 were suggested
to account for (or at least contribute to) 49% of the vari-
ance in VO2max trainability (included in Table 4; p < 0.05).
The strongest predictors were found in SNPs associated
with: PR domain-containing protein 1 (PRDM1); glutam-
ate receptor, ionotropic, N-methyl-D-aspartate 3A
(GRIN3A); N-methyl-D-aspartate receptor (NMDA); po-
tassium voltage-gated channel subfamily H member 8
(KCNH8); zinc finger protein of cerebellum 4 (ZIC4); and,
ACSL1. An unweighted ‘predictor score’ based on contri-
bution to VO2max of these 21 variants was created. A score
of ‘0’ represented homozygote for the low-response vari-
ant; ‘1’ represented heterozygous and ‘2’ represented
homozygous for the high-response allele. Individuals with
a score equal to or less than 9 (n = 36) had an average
VO2max score improvement of 221 mL O2/min. Alterna-
tively, those (n = 52) with a score equal to or greater than
19 had an average VO2max increase of 604 mL/min.
The 15 most significant variants were tested for repli-
cation in a sample of African-Americans from the HERI-
TAGE study, women in the Dose Response to Exercise
(DREW) study (n = 112), and the men and women in the
Study of a Targeted Risk Reduction Intervention through
Defined Exercises (STRRIDE) (n = 183) [20]. Variants in
the NDN (15:g.24008071 T > C; rs824205) and DAAM1
(14:g.59477414C > T; rs1956197) were replicated in the
DREW study, the Z1C4 (3:g.146957166 T > C T;
rs11715829) variant was replicated in the STRRIDE
study and CAMTA1 (7:g.7015105 T > C; rs884736) and
RGS18 (1:g.192059022G > A; rs10921078) variants were
replicated in African-Americans from the HERITAGE
study. Four variants in the genes supervillin (SVIL), neu-
ropillin 2 (NRP2), titin (TTN) and carbozypeptidase
(CPVL) identified by Timmons et al. [28] were also
found by Bouchard et al. [20], however, at a significance
of 0.008, these variants were not included in the multi-
variate regression analysis.
Using the HERITAGE cohort, an extended analysis
was performed, with 2.5 million variants analysed [21].
To reduce bias associated with outlier variants, the sec-
ond most significant variant p-value was used to
determine genotype and changes in VO2max. Even with
an extended analysis, the ACSL1 gene was shown to
have the most significant variant (4:g.185725416A > G;
rs6552828), which confirmed findings by Bouchard et al.
[20], whom identified the most significant variant at
each gene (Table 3). The following genes and their vari-
ants were also replicated in both studies: CAMTA1
(rs884736), RYR2 (rs7531957), g.63226200G > A
(rs6090314), C12orf36 (rs12580476) and CD44
(rs353625) [20, 21].
The gene prioritisation tool ‘CANDID’ was then used
to rank candidate genes for changes in VO2max [21]. This
was done via: 1) a weighted analysis based on variant
gene expression in targeted tissues; 2) GWAS p-value
change in VO2max; 3) literature related to candidate
genes; and 4) ‘cross species sequence conservation’ [21].
The top-ranking candidate genes from the GWAS and
CANDID tool (Table 1) were then investigated for pos-
sible biological mechanisms and changes in VO2max. As
a result, variants were allocated into four groups: 1)
broad effects on exercise-related processes (such as the
electron transport chain, physical fitness, skeletal devel-
opment and other cardiorespiratory markers); 2) moder-
ately strong scores against selective exercise-related
processes; 3) high and low scores across several
exercise-related processes; 4) low scores across all
exercise-related processes.
Variants and their involvement in pathways related
to changes in VO2max response were then examined
[21]. Out of the sixteen pathways found, variants re-
lated to pantothenate and co-enzyme A (CoA) biosyn-
thesis, PPAR gene signalling and immune function
signalling had the highest level of ‘burden’ (variants
contributing to trainability). The variants related to
long-chain fatty acid transport (including ACSL1) and
fatty acid oxidation strongly influence VO2max training
response via lipid metabolism process and the tricarb-
oxylic acid cycle, both of which affect the availability
of adenosine triphosphate and subsequently training
response.
Predictor genes
Out of the 35 articles analysed (candidate genes and
GWAS studies), 97 predictor genes were identified as
possible contributors to VO2max trainability (Table 4).
These genes were based on what authors deemed sig-
nificant, or the most significant, for their particular
study. Thirteen of these predictor genes were replicated
between at least two studies (bolded in Table 4). The
traits for VO2max trainability (e.g. which genotype was
related to the training effect and whether it was a low
or high responding genotype) was not outlined for each
variant and hence this will require confirmation in
future studies.
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Discussion
This systematic review aimed to summarize genetic vari-
ants that have been identified as influencing VO2max
trainability. We have reviewed 35 studies that have re-
ported 97 genes associated with an exercise training-
induced improvement in VO2max. It has been estimated
that VO2max trainability has a significant heritable com-
ponent of around 50% [39].
There were several studies that identified the same
variant, including: the lipid-related ACSL1:c.-32-
716 T > C (rs6552828) [20, 21] and skeletal muscle-
related AMPD1:c.133C > T [33, 46]; intra-cellular cal-
cium regulator RYR2:c.6166 + 552 T > G; cellular function-
related CD44 (rs3653625), transcriptional activator
CAMTA1 (rs884736), non-coding C12orf36 (rs12580476)
and apoptotic regulator 20:g.63226200G > A (rs6090314)
[20, 21]. Additionally, Bouchard et al. [20] were able to rep-
licate the variants in genes from the HERITAGE study,
including: growth suppressor NDN, cell cortex
function-related DAAM1, development-related Z1C4
and signal transduction inhibitor RGS18. Numerous
identified variants were found in pathways that contri-
bute to training response (e.g. calcium signaling, im-
mune function, angiogenesis, mitochondrial biogenesis)
with pathways and associated SNPs possibly influencing
each other and overall trainability [21]. Several articles
found conflicting results with electrolyte balance, lipid pro-
duction and energy production genes ACE [25, 31, 47, 48],
APOE [13, 23, 41, 42], mtDNA [49, 50] and CKMM vari-
ants respectively [26, 27, 29, 40]. All other ‘predictor genes’
identified are yet to be replicated.
While most of the articles examined in this review
have focused on one or a few candidate genes/markers
(n = 32), it is noted that exercise-related phenotypes are
complex traits and are polygenic (i.e. influenced by many
genes working together) with each genetic variant likely
to be contributing a small percentage (typically less than
1%) to the overall change in VO2max [33, 39, 61]. Thus
relying on one variant as a predictor is misguided; rather
it has been suggested that a gene predictor score (GPS)
based on numerous variants has a greater probability to
determine higher and lower responders for VO2max
trainability. For example, a score of ‘0’ represents a
homozygote for a low-response variant; ‘1’ represents
heterozygous and ‘2’ represents homozygous for a high-
response variant [20]. A higher score indicates a greater
possible VO2max training response (and vice versa). A
similar model has been suggested in elite athletes aiming
to determine the probability of an individual with a the-
oretically ‘optimal’ polygenic profile for endurance
sports. The ‘optimal’ profile using a so-called ‘total geno-
type score’ (TGS, ranging from 0 to 100, with ‘0’ and
‘100’ being the worst and best genotype combinations,
respectively) was quantified from a simple algorithm
resulting from the combination of candidate polymor-
phisms [62, 63].
These predictor genes, along with muscle RNA and pro-
tein expression data provide a sound platform to further
explore the cellular mechanisms underlying VO2max train-
ability. Further research will need to consider several limi-
tations identified from the literature to-date. For example,
the lack of replication found between articles and conflict-
ing results with certain variants, may be a result of several
main limitations (typically in study design). Firstly, most
of the articles used a hypotheses-driven candidate gene
approach (n = 32), several articles used retrospective data
from similar cohorts (n = 19), and many lacked a control
group and randomization (n = 31). While it is understand-
able that in the past, high-throughput SNP microarray or
gene sequencing technology was not available to use, by
looking at one or only a few gene variants (whereas it is
estimated that the human genome consists of about 40
million common gene variants) it is almost impossible to
generate meaningful information. Similarly, a lack of con-
trol group makes it challenging to distinguish between in-
dividual response to an intervention and within-subject
random variation [64]. Secondly, most of the exercise
training studies involve a relatively small number of par-
ticipants (typically n = 20 to 30; with the exception of the
HERITAGE and CARAGENE studies), which results in
lack of statistical power when associating genotype with a
phenotype. Many of the studies also failed to include a ro-
bust significance criterion (p < 0.05 occurs approximately
106 times in the genome by chance). Thirdly, a lack of ra-
cial diversity (74.5% Caucasian) further reduces the power
of variants detected. Finally, many of the training studies
were not tightly controlled in terms of nutrition, partici-
pant baseline data (study entry), physical activity status
and other lifestyle factors.
Future research needs to consider epigenetic variation
of gene activity that can occur in reaction to external
factors, such as additional physical activity, drugs, diet
and environmental toxins [61, 65]. Such epigenetic
modifications can affect all adaptions to exercise train-
ing [10]. For example, in addition to nutrition and base-
line physical activity status, there were many other
differences in subjects between articles not taken into
consideration including: age, training duration and vol-
ume (MICT vs. HIIT), body weight, body fat percentage,
medications, clinical versus healthy populations; sleep,
psychological status and the gut microbiome. Together,
these are potential epigenetic modifiers (e.g. DNA
methylation and histone acetylation) that can influence
gene expression, molecular function and thereby influ-
ence VO2max training response [61, 66]. Whether genes
or epigenetic modifiers play a larger percentage role in
adaptive variability in a specific situation requires
further exploration.
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To address these limitations, larger-scale studies are re-
quired to ascertain if the 97 predictor genes identified
from this review are similar in various cohorts (e.g. several
ethnicities, ages, gender). The Athlome Project Consor-
tium, which includes the Gene SMART study, is an ex-
ample of a current larger-scale investigation examining
‘omic markers’ of training response, elite performance and
injury rates/predisposition in variety of populations [67].
Ideally, future studies will complement and expand on this
research, and consider alternative forms of exercise train-
ing intensity and volume, lifestyle factors, general health,
diet, medications and health history when implementing
interventions and analyzing data.
Furthermore, the role of the gut microbiome, and its
influence on metabolism and physiology, needs to be ex-
plored. For example, gut microbiota (which has its own
genome) can interact with the tissue cellular environ-
ment to regulate gene expression [61]. Poor diet, stress,
illness, the use of antibiotics, environmental toxins and
poor lifestyle choices can increase inflammation within
the gut, causing dysbiosis; this appears to contribute to
chronic diseases and other illnesses, irrespective of geno-
type, age and gender [68, 69]. Interestingly, VO2max was
recently shown to be related to gut microbial diversity in
a human cross-sectional study [70], suggesting a link
between VO2max and gut microbes. Pre- and probiotics,
resistant starch and a Mediterranean diet (dietary diver-
sification) can alter the gut microbiome [68]. Investiga-
ting how the gut and human genome interact to
positively influence VO2max is warranted.
With these points in mind, the analysis of stool sam-
ples, in addition to incorporating epigenetic, transcrip-
tion and proteomic analysis, may help to identify the
best aerobic training or lifestyle intervention to upregu-
late or downregulate certain genes, signaling pathways
and molecular responses required for a greater VO2max
training response. Implementing tightly-controlled stud-
ies examining various mediators (training intervention,
diet, lifestyle) and molecular biomarkers across various
populations will help to capture accurate information re-
lated to ideal traits for VO2max trainability.
Conclusion
In total, 97 genes that predicted VO2max trainability were
identified. Phenotype is dependent on several of these
genotypes/variants, which may contribute to approxi-
mately 50% of an individual’s VO2max trainability. Higher
responders to exercise training have more positive re-
sponse alleles (greater gene predictor score) than lower
responders. Whilst these findings are exciting, further
randomized-controlled research with larger and diverse
cohorts are needed. Additional exploration is required to
identify genetic variants and the mediators (training in-
tensity and volume, diet, drugs, other lifestyle factors)
that can potentially affect gene expression, molecular
function and training response. Findings from this re-
view and future research may assist clinicians to provide
precision evidence-based medicine centered on pheno-
type, contributing to the fight against chronic disease.
Pubmed, embase, cinahl and cochrane search terms
Pubmed search
gene*[ti] OR allele [tiab] OR SNP [tiab] OR genetic pro-
filing[tiab] OR genetic variant*[tiab] OR Genomic predic-
tor*[tiab] OR polymorphism[tiab] OR heritability[tiab]
AND (exercise training [tiab] OR VO2peak[tiab] OR
‘cardiorespiratory fitness’[tiab] OR ‘maximal/maximum
VO2peak’[tiab] OR maximal/maximum VO2max’[tiab]
OR maximal oxygen consumption’[tiab]OR peak oxygen
uptake’[tiab] OR interval exercise’[tiab] OR ‘high/low in-
tensity exercise’[tiab] OR peak fitness [tiab] OR enduran-
ce*[tiab] OR physical fitness[tiab] OR cardiorespiratory
fitness[tiab] OR endurance training [tiab] OR cardiovascu-
lar fitness[tiab] OR VO2max[tiab] OR aerobic power[tiab]
OR aerobic fitness[tiab] OR exercise capacity[tiab] OR ex-
ercise training response[tiab] OR response to exercise trai-
ning[tiab]) NOTanimal*.
Embase
gene:ab,ti OR allele:ab,ti OR snp:ab,ti OR ‘genetic profi-
ling’:ab,ti OR ‘genetic variant’:ab,ti OR ‘genomic predic-
tor’:ab,ti OR heritability:ab,ti AND (vo2peak:ab,ti OR
vo2max:ab,ti OR ‘cardiovascular fitness’:ab,ti OR ‘cardio-
respiratory fitness’:ab,ti OR ‘aerobic power’:ab,ti OR ‘aer-
obic fitness’:ab,ti OR ‘exercise training response’:ab,ti OR
‘physical fitness’:ab,ti).
Cinahl
(genes OR ‘genetic variant’ OR ‘Genomic predictor’ OR
polymorphism OR ‘genetic profiling’ OR ‘single nucleo-
tide polymorphisms’ OR ‘SNPs’ heritability) AND (‘train-
ability’ OR’ cardiovascular fitness’ OR ‘interval exercise’
OR ‘maximum O2’ OR maximal oxygen consumption’
OR ‘peak oxygen consumption’ OR maximal aerobic
capacity’ OR ‘high/low intensity exercise’ OR ‘cardiore-
spiratory fitness’ OR ‘aerobic power’ OR ‘response to ex-
ercise training’ OR ‘exercise capacity’ OR ‘VO2max’ OR
‘VO2peak’ OR endurance).
Cochrane database for systematic reviews
(genes OR ‘genetic variant’ OR ‘Genomic predictor’ OR
polymorphism OR ‘genetic profiling’ OR ‘single nucleo-
tide polymorphisms’ OR ‘SNPs’ OR heritability) AND
(‘trainability’ OR’ cardiovascular fitness’ OR ‘interval ex-
ercise’ OR ‘maximum O2’ OR maximal oxygen con-
sumption’ OR ‘peak oxygen consumption’ OR maximal
aerobic capacity’ OR ‘high/low intensity exercise’ OR
‘cardiorespiratory fitness’ OR ‘aerobic power’ OR
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‘response to exercise training’ OR ‘exercise capacity’ OR
‘VO2max’ OR ‘VO2peak’ OR endurance).
Cochrane central register of controlled trial
(genes OR ‘genetic variant’ OR ‘Genomic predictor’ OR
polymorphism OR ‘genetic profiling’ OR ‘single nucleo-
tide polymorphisms’ OR ‘SNPs’ heritability) AND (‘train-
ability’ OR’ cardiovascular fitness’ OR ‘cardiorespiratory
fitness’ OR ‘interval exercise’ OR ‘maximum O2’ OR
maximal oxygen consumption’ OR ‘peak oxygen con-
sumption’ OR maximal aerobic capacity’ OR ‘high/low
intensity exercise’ OR ‘aerobic power’ OR ‘response to
exercise training’ OR ‘exercise capacity’ OR ‘VO2max’
OR ‘VO2peak’ OR endurance).
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